Yahoo Web Search

  1. Yahoo Finance Results

  2. Investors focused on the Medical space have likely heard of Allergan plc (AGN), but is the stock performing well in comparison to the rest of its sector peers? Let's take a closer ...

  3. This could indicate that investors who seek to profit from falling equity prices are not currently targeting AGN. Index (PMI) data, output in the Healthcare sector is rising. To the fullest ...

  4. Value investing is easily one of the most popular ways to find great stocks in any market environment. A key metric that value investors always look at is the Price to Earnings Ratio, or PE for short.

  5. AGN vs. AMPH: Which Stock Is the Better Value Option?

    Zacks via Yahoo FinanceJul 02 13:30 PM

    Generic Drugs sector have probably already heard of Allergan (AGN) and Amphastar Pharmaceuticals (AMPH). There are plenty of strategies for discovering value stocks, but we have found ...

  6. Adamis (ADMP) Surges Following Novartis Deal for Symjepi

    Zacks via Yahoo FinanceJul 03 12:41 PM

    Shares of Adamis Pharmaceuticals ADMP surged 50% after the company announced that it entered into an exclusive distribution and commercialization agreement for its Symjepi (epinephrine) with ...

  7. Monday, July 2, 2018 The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Bank of ...

  8. Today's Research Daily features new research reports on 16 major stocks, including Union Pacific (UNP), Twenty-First Century Fox (FOXA) and BP plc (BP). These research reports have been ...

  9. Stocks recently featured in the blog include Bank of America BAC, Wells Fargo WFC and Honeywell HON, Allergan AGN and Enterprise Products Partners EPD. The Zacks Research Daily presents ...

  10. Galmed Pharmaceuticals Ltd (NASDAQ: GLMD ) earned another bullish analyst this week with a positive rating from Cantor Fitzgerald. The coverage comes with a valuation that implies 459-percent upside. The ...

  11. Novartis Looks to Exit Antibacterial, Antiviral Program

    Zacks via Yahoo FinanceJul 13 19:09 PM

    As per a statement released by media sources, Novartis AG NVS is all set to exit its antibacterial and antiviral research program. The Swiss pharma giant also plans to reduce the headcount at ...